Navigation Links
Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
Date:9/25/2007

on the quality of life for residents. The study also showed that youth from public housing who participated in a Boys & Girls Club had a higher percentage of academic achievement and fewer behavioral problems in school.

"The Regence Boys & Girls Club is a true beacon of hope for the youth of this community who need us most," said Lisabeth Marziello, chief executive officer of the Boys & Girls Clubs of Portland Metropolitan Area. "Regence's demonstration of leadership through this investment will have a direct impact upon the young people of this community by changing the landscape of opportunities available. The Regence Boys & Girls Club will be a place where kids can play, have fun, experience joy, laugh, and learn about themselves and the larger world they live in. But most importantly, the Club will be a place where children will receive positive guidance that nurtures their character and enables them to become productive, responsible and caring adults who give back to their community."

About Boys & Girls Clubs

Boys & Girls Clubs of America comprises a national network of some 4,200 neighborhood-based facilities annually serving more than 4.4 million young people, primarily from disadvantaged circumstances. Known as "The Positive Place for Kids," Clubs provide guidance-oriented programs on a daily basis for children 6 - 18 years old, conducted by a full-time professional staff. Key programs emphasize character and leadership development, educational enhancement, career preparation, health and life skills, the arts, and sports, fitness and recreation. Locally, the Boys & Girls Clubs of Portland Metropolitan Area has established itself as the premier youth guidance and development agency, providing nationally proven life-saving programs to more than 13,000 young people throughout Portland and its surrounding communities.

About Regence BlueCross BlueShield of Oregon

Regence BlueCross BlueShield of Oregon provides medical, dental and rel
'/>"/>

SOURCE Regence BlueCross BlueShield of Oregon
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
2. Taking Care Of Grandkids Can Give Women more than a Headache
3. British Grandmother has timely bypass surgery in India
4. Grandma Recovers Eyesight Miraculously
5. A Potent Sedative Kills Great-grandfather
6. Grand FDA nod and approval for drug for heart transplant patients
7. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
8. Grandparents Care Makes Grandchildren More Caring for Them
9. Opening of Mental Health Rehabilitation Unit Uncertain
10. Eating disorder in Diabetic girls lead to eyesight damage.
11. Gene linked to early puberty in girls
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 1Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 2Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 3Journal of Public Health Management 26amp 3B Practice Calls for Growth in Public Health Workforce 60859 1Journal of Public Health Management 26amp 3B Practice Calls for Growth in Public Health Workforce 60859 2Journal of Public Health Management 26amp 3B Practice Calls for Growth in Public Health Workforce 60859 3Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 60856 1Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 60856 2Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 60856 3